I
Ian D. Pavord
Researcher at University of Oxford
Publications - 654
Citations - 55329
Ian D. Pavord is an academic researcher from University of Oxford. The author has contributed to research in topics: Asthma & Sputum. The author has an hindex of 108, co-authored 575 publications receiving 47691 citations. Previous affiliations of Ian D. Pavord include John Radcliffe Hospital & University of Warwick.
Papers
More filters
Journal ArticleDOI
Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease
Michael A Ghebre,Mona Bafadhel,Dhananjay Desai,Suzanne Cohen,Paul Newbold,Laura Rapley,Jo Woods,Paul Rugman,Ian D. Pavord,Chris Newby,Paul Burton,Richard D. May,Christopher E. Brightling +12 more
TL;DR: Sputum cytokine profiling can determine distinct and overlapping groups of subjects with asthma and COPD, supporting both the British and Dutch hypotheses and may contribute to improved patient classification to enable stratified medicine.
Journal ArticleDOI
Cough and Glottic-Stop Reflex Sensitivity in Health and Disease
B Prudon,Surinder S. Birring,Dhiraj D. Vara,Andrew P. Hall,Jonathan P. Thompson,Ian D. Pavord +5 more
TL;DR: There was a reasonably close relationship between cough sensitivity and glottic-stop reflex sensitivity, indicating either that the cough reflex and the glOTTic- stop reflex share a common pathway or that subjects who have a chronic cough have a global abnormality of upper airway reflexes.
Journal ArticleDOI
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma.
William W. Busse,Jorge Maspero,Klaus F. Rabe,Alberto Papi,Sally E. Wenzel,Linda B. Ford,Ian D. Pavord,Bingzhi Zhang,Heribert Staudinger,Gianluca Pirozzi,Nikhil Amin,Bolanle Akinlade,Laurent Eckert,Jingdong Chao,Neil M.H. Graham,Ariel Teper +15 more
TL;DR: This phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with persistent asthma who are receiving continuous treatment with inhaled corticosteroids plus one or two other asthma controller medicines examines the efficacy of dupilumab in this at-risk patient population.
Journal ArticleDOI
Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
Michael E. Wechsler,Marcella Ruddy,Ian D. Pavord,Elliot Israel,Klaus F. Rabe,Linda B. Ford,Jorge Maspero,Raolat M Abdulai,Chih-Chi Hu,Renata Martincova,Andreas Jessel,Michael C Nivens,Nikhil Amin,David M. Weinreich,George D. Yancopoulos,Helene Goulaouic +15 more
TL;DR: In this article, a new monoclonal antibody targeting IgE, interleukin-4 and -13 is proposed for treating severe type 2 asthma, but new targets are needed.
Journal ArticleDOI
Measurement of exhaled nitric oxide concentration in asthma: a systematic review and economic evaluation of NIOX MINO, NIOX VERO and NObreath.
Susan Harnan,Paul Tappenden,Munira Essat,Tim Gomersall,Jon Minton,Ruth Wong,Ian D. Pavord,Mark L. Everard,Rod Lawson +8 more
TL;DR: Assessment of the diagnostic accuracy, clinical effectiveness and cost-effectiveness of the hand-held electrochemical devices NIOX MINO, NioX VERO, and NObreath for the diagnosis and management of asthma found varying levels of agreement between monitors, with better agreement at lower FeNO values.